Lauren Price

2.7k total citations
22 papers, 582 citations indexed

About

Lauren Price is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Lauren Price has authored 22 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Biomedical Engineering. Recurrent topics in Lauren Price's work include Nanoparticle-Based Drug Delivery (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Lauren Price is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Lauren Price collaborates with scholars based in United States and United Kingdom. Lauren Price's co-authors include William C. Zamboni, Joseph Piscitelli, Allison M. Deal, Stęphan T. Stern, Alexander V. Kabanov, Nina Isoherranen, Jennifer E. Sager, Allison N. Schorzman, Andrew T. Lucas and Samuel K. Lai and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Lauren Price

20 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lauren Price United States 13 210 153 148 127 85 22 582
Shujun Shentu United States 11 417 2.0× 139 0.9× 141 1.0× 212 1.7× 77 0.9× 20 838
Saini Setua United States 12 248 1.2× 231 1.5× 123 0.8× 118 0.9× 82 1.0× 24 595
Abdullah Farooque India 13 332 1.6× 156 1.0× 204 1.4× 164 1.3× 87 1.0× 20 878
Andreas Baumann Germany 16 304 1.4× 121 0.8× 86 0.6× 70 0.6× 186 2.2× 31 880
Qiuxia Yang China 16 384 1.8× 126 0.8× 49 0.3× 121 1.0× 63 0.7× 78 844
Wenyi Zheng Sweden 16 386 1.8× 61 0.4× 66 0.4× 84 0.7× 40 0.5× 50 753
Fei You United States 16 328 1.6× 107 0.7× 61 0.4× 40 0.3× 73 0.9× 31 662
Longzhu Piao United States 18 473 2.3× 132 0.9× 194 1.3× 97 0.8× 19 0.2× 25 863
Qie Guo China 13 209 1.0× 100 0.7× 89 0.6× 60 0.5× 21 0.2× 41 497
JingXia Cui China 19 400 1.9× 101 0.7× 376 2.5× 155 1.2× 34 0.4× 27 736

Countries citing papers authored by Lauren Price

Since Specialization
Citations

This map shows the geographic impact of Lauren Price's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren Price with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren Price more than expected).

Fields of papers citing papers by Lauren Price

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren Price. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren Price. The network helps show where Lauren Price may publish in the future.

Co-authorship network of co-authors of Lauren Price

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren Price. A scholar is included among the top collaborators of Lauren Price based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren Price. Lauren Price is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Baines, Andrea, Bindu Kanapuru, Lauren Price, et al.. (2024). FDA Approval Summary: Teclistamab–A Bispecific CD3 T-Cell Engager for Patients with Relapsed or Refractory Multiple Myeloma. Clinical Cancer Research. 30(24). 5515–5520. 7 indexed citations
3.
Pulte, Dianne, Haiyan Chen, Lauren Price, et al.. (2022). FDA Approval Summary: Revised Indication and Dosing Regimen for Ponatinib Based on the Results of the OPTIC Trial. The Oncologist. 27(2). 149–157. 32 indexed citations
4.
Kasamon, Yvette L., Lauren Price, Ólanrewaju O. Okusanya, et al.. (2021). FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. The Oncologist. 26(10). 879–886. 25 indexed citations
5.
Doyle, Hester A., Renelle J. Gee, Carmen J. Booth, et al.. (2021). Vaccine-induced ErbB (EGFR/HER2)-specific immunity in spontaneous canine cancer. Translational Oncology. 14(11). 101205–101205. 15 indexed citations
6.
Price, Lauren, Joseph Piscitelli, Charlene Santos, et al.. (2021). Minibeam radiation therapy enhanced tumor delivery of PEGylated liposomal doxorubicin in a triple-negative breast cancer mouse model. Therapeutic Advances in Medical Oncology. 13. 4277465732–4277465732. 5 indexed citations
7.
Price, Lauren, Stęphan T. Stern, Allison M. Deal, Alexander V. Kabanov, & William C. Zamboni. (2020). A reanalysis of nanoparticle tumor delivery using classical pharmacokinetic metrics. Science Advances. 6(29). eaay9249–eaay9249. 98 indexed citations
8.
McSweeney, Morgan D., Lauren Price, Timothy Wessler, et al.. (2019). Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG. Journal of Controlled Release. 311-312. 138–146. 70 indexed citations
9.
McSweeney, Morgan D., Timothy Wessler, Lauren Price, et al.. (2018). A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse. Journal of Controlled Release. 284. 171–178. 66 indexed citations
10.
11.
12.
Vader, Willemijn, Lauren Price, Bram Herpers, & Sander Basten. (2017). 3D Cultured Tumour from Patients to Predict Treatment Response. Annals of Oncology. 28. v451–v451. 1 indexed citations
13.
14.
Lucas, Andrew T., Lauren Price, Allison N. Schorzman, & William C. Zamboni. (2017). Complex Effects of Tumor Microenvironment on the Tumor Disposition of carrier-mediated Agents. Nanomedicine. 12(16). 2021–2042. 12 indexed citations
15.
Sager, Jennifer E., Sasmita Tripathy, Lauren Price, et al.. (2016). In vitro to in vivo extrapolation of the complex drug-drug interaction of bupropion and its metabolites with CYP2D6; simultaneous reversible inhibition and CYP2D6 downregulation. Biochemical Pharmacology. 123. 85–96. 31 indexed citations
16.
Sager, Jennifer E., Lauren Price, & Nina Isoherranen. (2016). Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4′-OH-bupropion in vitro. Drug Metabolism and Disposition. 44(10). 1709–1719. 37 indexed citations
17.
Diaz, Philippe, Weize Huang, Lauren Price, et al.. (2016). Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase. Journal of Medicinal Chemistry. 59(6). 2579–2595. 15 indexed citations
18.
Stamps, Blake W., Jarrod B. King, Lauren Price, et al.. (2014). Genomic and Metabolomic Insights into the Natural Product Biosynthetic Diversity of a Feral-Hog-Associated Brevibacillus laterosporus Strain. PLoS ONE. 9(3). e90124–e90124. 24 indexed citations
19.
Price, Lauren, et al.. (2011). Management of adrenal incidentaloma: are we getting it right?. 25. 1 indexed citations
20.
Yule, S. Murray, Alan V. Boddy, Michael Cole, et al.. (1995). Cyclophosphamide metabolism in children.. PubMed. 55(4). 803–9. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shujun Shentu Breakdown of academic impact, for papers by Saini Setua Breakdown of academic impact, for papers by Abdullah Farooque Breakdown of academic impact, for papers by Andreas Baumann Breakdown of academic impact, for papers by Qiuxia Yang Breakdown of academic impact, for papers by Wenyi Zheng Breakdown of academic impact, for papers by Fei You Breakdown of academic impact, for papers by Longzhu Piao Breakdown of academic impact, for papers by Qie Guo Breakdown of academic impact, for papers by JingXia Cui
Rankless by CCL
2026